Abstract
Flavonoids are polyphenolic compounds of very important class of plant secondary metabolites having a broad spectrum of biological activities. Because of their antioxidative, anti-inflammatory, antimutagenic, and anticarcinogenic properties, flavonoids have become an indispensable component in nutraceuticals, pharmaceuticals, medicinal, and cosmetic applications. The bioavailability, metabolism, and biological activities of many flavonoids have drawn the attention of researchers to use them as an alternative source of therapeutics for the treatment of various diseases; flavonoids have been shown to disrupt the initiation, promotion, and progression of cancer by modulating various signaling pathways and their downstream components associated with cellular proliferation, differentiation, inflammation, apoptosis, metastasis, angiogenesis, and reversal of multidrug resistance. Many natural flavonoids and their synthetic analogs are being investigated for their potential applications in anticancer therapies, because of their multi-targeted mechanism of action. Thus, the aim of the present chapter is to highlight the new insights on the recent progress of flavonoids as effective candidates in cancer therapeutics and prevention.
Irfan A. Ansari and Mohd Sayeed Akhtar have equally contributed for this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agati G, Biricolti S, Guidi L, Ferrini F, Fini A, Tattini M (2011) The biosynthesis of flavonoids is enhanced similarly by UV radiation and root zone salinity in L. vulgare leaves. J Plant Physiol 168:204–212
Avila MA, Velasco JA, Cansado J, Notario V (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54:2424–2428
Avila MA, Velasco JA, Harter KW, Velasco JA, Notario V (1996) Quercetin as a modulator of the cellular neoplastic phenotype. Adv Expl Med Biol 401:101–110
Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR (2000) Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 68:468–477
Benyhe S (1994) Morphine: new aspects in the study of an ancient compound. Life Sci 55:969–979
Berli FJ, Moreno D, Piccoli P, Hespanhol-Viana L, Silva MF, Bressan-Smith R, Cavagnaro JB, Bottini R (2010) Abscisic acid is involved in the response of grape (Vitis vinifera L.) cv. Malbec leaf tissues to ultraviolet-B radiation by enhancing ultraviolet-absorbing compounds, antioxidant enzymes and membrane sterols. Plant Cell Environ 33:1–10
Bidart-Bouzat MG, Imeh-Nathaniel A (2008) Global change effects on plant chemical defenses against insect herbivores. J Integr Plant Biol 50:1339–1354
Bourgaud F, Gravot A, Milesi S, Gontier E (2001) Production of plant secondary metabolites: a historical perspective. Plant Sci 161:839–851
Boutin JA (1994) Tyrosine protein kinase inhibition and cancer. Int J Biochem 26:1203–1226
Bowles D, Isayenkov J, Lim EK, Poppenberger B (2005) Glycosyltransferases: managers of small molecules. Curr Opin Plant Biol 8:254–263
Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87:595–600
Chan HJ, Ji YL, Chul HC, Chang JK (2007) Anti-asthmatic action of quercetin and rutin in conscious Guinea-pigs challenged with aerosolized ovalbumin. Arch Pharma Res 30:1599–1607
Chen J, Zhao H, Wang X, Lee FSC, Yang H, Zheng L (2008) Analysis of major alkaloids in Rhizoma coptidis by capillary electrophoresis-electrospray-time of flight mass spectrometry with different background electrolytes. Electrophoresis 29:2135–2147
Chen H, Miao Q, Geng M, Liu J, Hu Y, Tian L, Pan J, Yang Y (2013) Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci World J 2013:269165
Chung FL (1995) Inhibition of lung tumorigenesis by administration of a polyphenol. US Patent No. US5391568
Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL (1993) Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85:570–574
Cody V (1988) Plant flavonoids in biology and medicine part II. Prog Clin Biol Res 280:461
Cornell HV, Hawkins BA (2003) Herbivore responses to plant secondary compounds: a test of phytochemical coevolution theory. Am Nat 161:507–522
de Groot H (1994) Reactive oxygen species in tissue injury. Hepatogastroenterol 41:328–332
Dechaud H, Ravard C, Claustrat F, de la Perriere AB, Pugeat M (1999) Xenoestrogen interaction with human sex hormone–binding globulin (hSHBG). Steroids 64:328–334
Deschner EE, Ruperto JF, Wong GY, Newmark HL (1993) The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20:199–204
DeVita NT, Hellman S, Rosenberg SA (1997) Cancer: principles and practice of oncology, 5th edn. Lippencott-Raven, Philadelphia
Dixon RA (2001) Natural products and plant disease resistance. Nature 411:843–847
Dixon RA, Ferreira D (2002) Genistein. Phytochemistry 60:205–211
Dresser GK, Spence JD, Bailey DG (2000) Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 38:41–57
Elia G, Amici C, Rossi A, Santoro MG (1996) Modulation of prostaglandin A1-induced thermotolerance by quercetin in human leukemic cells: role of heat shock protein. Cancer Res 56:210–217
Empie M, Gugger E (2005) Method of preparing and using compositions extracted from vegetable matter for the treatment of cancer. US Patent No. US6900240
Ferrer J, Austin M, Stewart CJ, Noel J (2008) Structure and function of enzymes involved in the biosynthesis of phenylpropanoids. Plant Physiol Biochem 46:356–370
Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats G (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2:659–668
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57:2916–2921
Gerdin B, Srensso E (1983) Inhibitory effect of the flavonoid on increased microvascular permeability induced by various agent in rat skin. Int J Microcir Clin Exp 2:39–46
Grace PA (1994) Ischaemia-reperfusion injury. Br J Surg 81:637–647
Guon TE, Sook Chung HA (2016) Hyperoside and rutin of Nelumbo nucifera induce mitochondrial apoptosis through a caspase-dependent mechanism in HT-29 human colon cancer cells. Oncol Lett 11:2463–2470
Halliwell B (1995) How to characterize an antioxidant: an update. Biochem Soc Symp 61:73–101
Halliwell B (2002) Effect of diet on cancer development: is oxidative DNA damage a biomarker. Free Rad Biol Med 32:968–974
Hanasaki Y, Ogawa S, Fukui S (1994) The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Rad Biol Med 16:845–850
Harbone JB (1993) The flavonoids. Advance in research since 1986. Chapman and Hall, London
Heller W, Forkmann G (1988) Biosynthesis. In: Harborne JB (ed) The Flavonoids. Chapman and Hall, London, pp 399–425
Huang M, Gao H, Chen Y, Zhu H, Cai Y, Zhang X, Miao Z, Jiang H, Zhang J, Shen H, Lin L, Lu W, Ding J (2007) Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin Cancer Res 13:1298–1307
Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, Park YB, Choi MS (2002) Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clin Chim Acta 317:181–190
Jiang BH, Fang J (2006) Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents. US Patent No. US20060189680
Karuppusamy S (2009) A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J Med Plants Res 3:1222–1239
Kelly EH, Anthony RT, Dennis JB (2002) Flavonoid antioxidants: chemistry, metabolism and structure-actvity relationships. Nutri Biochem 13:572–584
Kerry NL, Abbey M (1997) Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135:93–102
Kidd PS, Llugany M, Poschenrieder C, Gunse B, Barcelo J (2001) The role of root exudates in aluminium resistance and silicon induced amelioration of aluminium toxicity in three varieties of maize (Zea mays L.). J Exp Bot 52:1339–1352
Kim HP, Mani I, Iverson L, ZIboh VA (1998) Effects of naturally occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipooxygenase in Guinea pigs. Prostaglandins Leukot. Essent Fatty Acids 58:17–24
Kliebenstein DJ (2004) Secondary metabolites and plant/environment interactions: a view through Arabidopsis thaliana tinged glasses. Plant Cell Environ 27:675–684
Knekt P, Jarvinen R, Seppanen R, Hellövaara M, Teppo L, Pukkala E, Aromaa A (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223–230
Korkina LG, Afanasev IB (1997) Antioxidant and chelating properties of flavonoids. Adv Pharmacol 38:151–163
Kuhn BM, Geisler M, Bigler L, Ringli C (2011) Flavonols accumulate asymmetrically and affect auxin transport in Arabidopsis. Plant Physiol 156:585–595
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinol 139:4252–4263
Kukic J, Petrovic C, Niketic M (2006) Antioxidant activity of four endemic Stachys taxa. Biol Pharma Bull 29:725–729
Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J 2013:162750
Kuntz S, Wenzel U, Daniel H (1999) Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38:133–142
Kurowska EM, Borradaile NM, Spence JD, Carrol CC (2000a) Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutr Res 20:121–129
Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piche LA, Serratore P (2000b) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72:1095–1100
Kusano M, Tohge T, Fukushima A, Kobayashi M, Hayashi N, Otsuki H, Kondou Y, Goto H, Kawashima M, Matsuda F, Niida R, Matsui M, Saito K, Fernie AR (2011) Metabolomics reveals comprehensive reprogramming involving two independent metabolic responses of Arabidopsis to UV-B light. Plant J 67:354–369
Lea AJ, Tung J, Zhou XA (2015) Flexible, efficient binomial mixed model for identifying differential dna methylation in bisulfite sequencing data. PLoS Genet 11:e1005650
Lee MR (2011) The history of Ephedra (ma-huang). J R Coll Physians Edinb 41:78–84
Lee SH, Jeong TS, Park YB, Kwon YK, Choi MS, Bok SH (1999) Hypocholesterolemic effect of hesperetin mediated by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A: cholesterol acyltransferase in rats fed high-cholesterol diet. Nutr Res 19:1245–1258
Lee SH, Ryu JK, Lee KY, Woo SM, Park JK, Yoo JW, Kim YT, Yoon YB (2008) Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett 259:39–49
Lesgards JF, Baldovini N, Vidal N, Pietri S (2014) Anticancer activities of essential oils constituents and synergy with conventional therapies: a review. Phytother Res 28:1423–1446
Levy J, Teuerstein I, Marbach M, Radian S, Sharoni Y (1984) Tyrosine protein kinase activity in the DMBAinduced rat mammary tumor: inhibition by quercetin. Biochem Biophys Res Commun 123:1227–1233
Lewis DR, Ramirez MV, Miller ND, Vallabhaneni P, Ray WK, Helm RF, Winkel BS, Muday GK (2011) Auxin and ethylene induce flavonol accumulation through distinct transcriptional networks. Plant Physiol 156:144–164
Liu Y (2004) Safe natural pharmaceutical composition for treating cancer. US Patent No. US20040072790A1
Loft S, Poulsen HE (1997) Cancer risk and oxidative DNA damage in man. J Mol Med 74:297–312
Ludwiczuk A, Skalicka-Wozniak K, Georgiev MI (2017) Terpenoids. In: Badal S, Delgoda R (eds) Pharmacognosy: fundamentals, applications and strategied. Elsevier, London, pp 233–266
Mahajan M, Ahuja PS, Yadav SK (2011) Post-transcriptional silencing of flavonol synthase mRNA in tobacco leads to fruits with arrested seed set. PLoS One 6:e28315
Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL, Bertagnolli MM (2000) Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21:921–927
Martens S, Preuss A, Matern U (2010) Multifunctional flavonoid dioxygenases: flavonols and anthocyanin biosynthesis in Arabidopsis thaliana L. Phytochemistry 71:1040–1049
Menon LG, Kuttan R, Kuttan G (1995) Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 95:221–225
Mishra A, Kumar S, Pandey AK (2013) Scientific validation of the medicinal efficacy of Tinospora cordifolia. Sci World J 2013:292934. https://doi.org/10.1155/2013/292934
Molnar J, Beladi I, Domonkos K, Földeák S, Boda K, Veckenstedt A (1981) Antitumor activity of flavonoids on NK/Ly ascites tumor cells. Neoplasma 28:11–18
Moroney MA, Alcaraz MJ, Forder RA, Carry F, Hoult JR (1988) Selectivity of 5-neutrophil oxygenase and lipoxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 40:787–792
Morre DM, Morre DJ (2007) Compositions based on vanilloid catechin synergies for prevention and treatment of cancer. US Patent No. US7192612B2
Namdeo AG (2007) Plant cell elicitation for production of secondary metabolites-a review. Pharmacogn Rev 1:69–79
Navarro-Perán E, Cabezas-Herrera J, del Campo LS (2007) Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol 39:2215–2225
Netke S, Niedzwiecki A, Rath M, Roomi WM (2006) Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer. US Patent No. US-7041699-B2
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weslon A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705–708
Nijveldt RJ, van Nood E, Danny EC, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PAM (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425
Oesterreich S, Weng CN, Qui M, Hilsenbeck SG, Osborne CK, Fuqua SAW (1993) The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 53:4443–4448
Oksman-Caldentey KM, Inze D (2004) Plant cell factories in the post-genomic era: new ways to produce designer secondary metabolites. Trends Plant Sci 9:433–440
Peer WA, Murphy AS (2007) Flavonoids and auxin transport: modulators or regulators. Trends Plant Sci 12:556–563
Pollak PE, Vogt T, Mo Y, Taylor LP (1993) Chalcone synthase and flavonol accumulation in stigmas and anthers of Petunia hybrida. Plant Physiol 102:925–932
Pryor WA (1997) Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105:S875–S882
Ramchoun M, Harnafi H, Alem C, Benlys M, Elrhaffari L, Amrani S (2009) Study on antioxidant and hypolipidemic effects of polyphenol rich extract from Thymus vulgaris and Lavandula multifida. Pharm Res 1:106–112
Ranelletti FO, Maggiano N, Serra FG, Ricci R, Larocca LM, Lanza P, Scambia G, Fattorossi A, Capelli A, Piantelli M (1999) Quercetin inhibits p21-ras expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer 85:438–445
Rath M, Netke S, Niedzwiecki AA (2006) Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer. US Patent No. US7041699B2
Rattan RR (2010) Mechanism of action of insecticidal secondary metabolites of plant origin. Crop Protect 29:913–920
Raut JS, Karuppayil SM (2014) A status review on the medicinal properties of essential oils. Indust Crops Prod 62:250–264
Rodriguez-Lopez JN, Navarro-Peran EM, Cabezas-Herrera J (2007) Dihydrofolate reductase inhibition by epigallocatechin gallate compounds. US Patent No. US20070249545A1
Rodriguez-Lopez JN, Cabezas-Herrera J, Navarro-Peran EM, Sanchez DCL (2008) Epigallocatechin-3-gallate compositions for cancer therapy and chemoprotection. Patent No. WO2008075201
Rosenberg RS, Grass L, Jenkins DJ, Kendall CW, Diamandis EP (1998) Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem Biophys Res Commun 248:935–939
Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S (1995) Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol 50:1485–1493
Ryan KG, Swinny EE, Markham KR, Winefield C (2002) Flavonoid gene expression and UV photoprotection in transgenic and mutant Petunia leaves. Phytochemistry 59:23–32
Sales PM, Souza PM, Simeoni LA, Magalhães PO, Silveira D (2012) Amylase Inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci 15:141–183
Schijlen EG, De Vos CH, Martens S, Jonker HH, Rosin FM, Molthoff JW, Tikunov YM, Angenent GC, Van Tunen AJ, Bovy AG (2007) RNA interference silencing of chalcone synthase, the first step in the flavonoid biosynthesis pathway, leads to parthenocarpic tomato fruits. Plant Physiol 144:1520–1530
Siddique YH, Beg T, Afzal M (2008) Antigenotoxic effect of apigenin against anti-cancerous drugs. Toxicol In Vitro 22:625–631
Stefani ED, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L (1999) Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34:100–110
Stracke R, Ishihara H, Huep G, Barsch A, Mehrtens F, Niehaus K, Weisshaar B (2007) Differential regulation of closely related R2R3-MYB transcription factors controls flavonol accumulation in different parts of the Arabidopsis thaliana seedling. Plant J 50:660–677
Tapas AR, Sakarkar DM, Kakde RB (2008) Flavonoids as nutraceuticals: a review. Trop J Pharma Res 7:1089–1099
Treutter D (2006) Significance of flavonoids in plant resistance: a review. Environ Chem Lett 4:147–157
Urso ML, Clarkson PM (2003) Oxidative stress, exercise, and antioxidant supplementation. Toxicology 189:41–54
van Acker FA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A (2000) Flavonoids can replace a-tocopherol as an antioxidant. FEBS Lett 473:145–148
van Der Meer IM, Stam ME, Van Tunen AJ, Mol JN, Stuitje AR (1992) Antisense inhibition of flavonoid biosynthesis in Petunia anthers results in male sterility. Plant Cell 4:253–262
Vattem DA, Randhir R, Shetty K (2005) Cranberry phenolics-mediated antioxidant enzyme response in oxidatively stressed porcine muscle. Process Biochem 40:2225–2238
Verdan AM, Wang HC, García CR, Henry WP, Brumaghim JL (2011) Iron binding of 3-hydroxychromone, 5-hydroxychromone, and sulfonated morin: implications for the antioxidant activity of flavonols with competing metal binding sites. J Inorg Biochem 105:1314–1322
Volate SR, Davenport DM, Muga SJ, Wargovich MJ (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26:1450–1456
Wasson AP, Pellerone FI, Mathesius U (2006) Silencing the flavonoid pathway in Medicago truncatula inhibits root nodule formation and prevents auxin transport regulation by Rhizobia. Plant Cell 18:1617–1629
Williams R, Spencer J, Rice-Evans C (2004) Flavonoids: antioxidants or signaling molecules. Free Rad Biol Med 36:838–849
Winkel-Shirley B (2002) Biosynthesis of flavonoids and effects of stress. Curr Opin Plant Biol 5:218–223
Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17–29
Wu Y (2007) The synergistically pharmaceutical composition of baicalein and baicalin for inhibiting tumor. Patent No. EP1849467
Yokoo T, Kitamura M (1997) Unexpected protection of glomerular mesangial cells from oxidant triggered apoptosis by bioflavonoid quercetin. Am J Phys 273:206–212
Yoon K, Pallaroni L, Stoner M, Gaido K, Safe S (2001) Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. J Steroid Biochem Mol Biol 78:25–32
Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, Aoike A (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10–13
Yoshida M, Yamamoto M, Nikaido T (1992) Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 52:6676–6681
Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S (2011) Antiviral activity of four types of bioflavonoid against dengue virus type-2. Vir J 8:560. https://doi.org/10.1186/1743-422X-8-560
Zerback R, Dressler K, Hess D (1989) Flavonoid compounds from pollen and stigma of Petunia hybrida: inducers of the vir region of the Agrobacterium tumefaciens Ti plasmid. Plant Sci 62:83–91
Zhao XX (2003) Plant drug for preventing cancer. US Patent No. US200318039
Zhu W, Jia Q, Wang Y, Zhang Y, Xia M (2012) The anthocyanin cyanidin-3-O-𝛽-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMPPKA- dependent signaling pathway. Free Rad Biol Med 2012:314–327
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ansari, I.A., Akhtar, M.S. (2019). Recent Insights on the Anticancer Properties of Flavonoids: Prospective Candidates for Cancer Chemoprevention and Therapy. In: Akhtar, M., Swamy, M., Sinniah, U. (eds) Natural Bio-active Compounds. Springer, Singapore. https://doi.org/10.1007/978-981-13-7154-7_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-7154-7_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7153-0
Online ISBN: 978-981-13-7154-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)